Melky Cabrera Getty

Giants beat writer apologizes to Melky Cabrera about PED rumor

35 Comments

Here’s something you don’t see every day: a writer apologizing to a player for giving life to a rumor of PED usage.

You see, there was a nasty rumor flying around on Twitter that Giants outfielder Melky Cabrera had tested positive for performance-enhancing drugs. Andrew Baggarly of CSNBayArea.com decided to ask Cabrera about it. Cabrera categorically denied the rumors, saying MLB hasn’t informed him or the players union about a positive test. He even contacted his agent to make sure. Baggarly then decided to pass along word of Cabrera’s denial. However, Baggarly later had regrets of acknowledging the rumor in the first place and issued a public apology to Cabrera.

Here’s part of the apology, which you can read in full on CSNBayArea.com:

We live in a different media universe and the rules are changing every day. Information is immediate. The level of interaction between fans and journalists is greater than ever. Anyone can self-publish any thought that rumbles through his or her head, true or untrue. It can be a confusing cacophony for any journalist, and it certainly is for me at times.

It’s my job to serve readers. But what if it’s just one tenth of one percent of my readership who are asking these questions? Is it my responsibility to respond to them in a public way?

Asking these questions from a different vantage point: If I were Melky Cabrera, would I appreciate a reporter who knocked down a rumor that was just a whisper in some corners of the Internet? Or would I be royally pissed to see my name mentioned alongside PEDs, no matter the context, by a credentialed, professional journalist?

It’s obvious, isn’t it? Well, it should have been obvious to me. It wasn’t.

In retrospect, I made the wrong decision to address these rumors on my Twitter account and disseminate it to my 30,000-plus followers.

So I feel it’s important that I issue a public apology to Melky Cabrera for giving greater voice to a rumor that, to the best of my knowledge and on his word, has absolutely no basis in fact.

It’s a good read on a sensitive topic and a cautionary tale for anyone who considers running with a rumor which could do some serious damage to someone’s reputation. Baggarly may have made a mistake to run with the rumor, but he deserves credit for holding himself accountable. If only we could say the same for those who continue to recklessly spread rumors of PED usage about the likes of Jeff Bagwell and Mike Piazza.

The Yankees are paying $86 million for a one-inning reliever

chapman
Leave a comment

OXON HILL, MD — The Yankees signing of Aroldis Chapman late Wednesday night came as something of a surprise. And the money — $86 million — was something of a shock. Yes, we knew that Chapman was going to break the bank and likely set a record as the highest paid relief pitcher in history, but seeing it in black and white like that is still rather jarring.

In the coming days, many people who attempt to analyze and contextualize this signing will do so by pointing to the 2016 playoffs and the unconventional use of relievers by Terry Francona and the Indians and Joe Maddon of the Cubs. They’ll talk about how the paradigm of bullpen use has shifted and how relief pitchers have taken on a new importance in today’s game. Chapman’s astronomical salary, therefore, will be described as somehow more reasonable and somewhat less shocking than it first seems.

Don’t buy that jive for a second.

Yes, Andrew Miller and, to some extent, Chapman himself were used unconventionally in the 2016 playoffs, but not long into the 2017 season we will see that as an exception, not the rule. And not just because Chapman showed himself unable to hold up to that level of use in the playoffs. It will be the exception because the Yankees have shown no inclination whatsoever to deviate from traditional bullpen usage in the past and there is no reason to expect that they will do so with Chapman in the future.

As you no doubt remember, the Yankees had Chapman, Dellin Betances and Andrew Miller for the first half of 2016. Such an imposing back end of a bullpen has rarely been seen in recent history. All of them, however, were used, more or less, as one-inning-a-piece guys and no real effort was ever made to break any bullpen usage paradigms or to shorten games the way many applauded Terry Francona for doing in the playoffs.

Miller pitched 44 games for the Yankees, totaling 45.1 innings. He pitched more than a single inning on only three occasions. Chapman pitched 31 games for the Yankees, amassing 31.1 innings. He was used for more than one inning only twice. Betances worked in 73 games, totaling 73 innings. On 11 occasions he pitched more than one inning.  It was unconventional for a team to have three relievers that good, but they were not, in any way, used unconventionally. Nor is there any reason to expect Chapman to be used unconventionally in 2017, especially given that Miller is not around and Chapman has shown no real ability to be stretched for multiple innings for a sustained period.

None of which is to say that having Chapman around is a bad thing or that he is any less of a closer than his reputation suggests. It’s merely to say that the Yankees paying Chapman unprecedented money for a closer should not be justified by the alleged new importance of relief pitchers or that changing role for them we heard so much about in the playoffs. Indeed, I suspect that that changing role applies only to pitcher use in the playoffs. And I do not suspect that this transaction alone pushes the Yankees into serious playoff contention, making that temporary unconventionality something of a moot point in New York for the foreseeable future.

It is almost certain that the Yankees are paying $86 million for the same one-inning closer Aroldis Chapman has been for his entire seven-year career. His contract may or may not prove to be a good one for New York based on how he performs, but don’t let anyone tell you now, in Decemeber 2016, that it’s better than you think because Chapman will somehow transform into a 1970s-style relief ace or something.

Report: Yankees sign Aroldis Chapman to a five-year, $86 million deal

gettyimages-577291896
Getty Images
9 Comments

Update (12:02 AM EST): Rosenthal adds that Chapman’s contract includes an opt-out clause after three seasons, a full no-trade clause for the first three years of the contract, and a limited no-trade clause for the final two years.

*

Ken Rosenthal of FOX Sports reports that the Yankees have signed closer Aroldis Chapman to a five-year, $86 million contract. Mark Melancon recently set the record for a contract earned by a reliever at $62 million over four years. Chapman blew that out of the water and many are surprised he didn’t fetch more.

Chapman, 28, began the 2016 season with the Yankees but he was traded to the Cubs near the end of July in exchange for four prospects. The Cubs, of course, would go on to win the World Series in large part due to Chapman. The lefty finished the regular season with a 1.55 ERA, 36 saves, and a 90/18 K/BB ratio in 58 innings between the two teams.

Chapman was the best reliever on the free agent market and, because he was traded midseason, he didn’t have draft pick compensation attached to him.

The Yankees don’t seem to be deterred by Chapman’s domestic violence issue from last offseason, resulting in a 30-game suspension to begin the 2016 regular season.